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In order to evaluate the role of calcium in the activation processes in eosinophils induced by platelet-activating factor 
(PAF), we investigated the changes in free cytoplasmatic Ca 2+ concentration using fura-2. PAF causes a rapid and tran- 
sitory rise of the intracellular f ee calcium ion concentration ([Ca2+]i) n purified guinea pig eosinophils of approx. 1000 
nM above a basal evel of 120.7+ 36.5 nM (n= 10). The effect was dose-related with a maximum rise at 1000 nM PAF 
and an ECso of 17.4 nM and specifically inhibited by the PAF antagonist WEB 2086 with an IC5o of 95.5 nM. WEB 
2086 did not affect either the leukotriene B 4- or the fMet-Leu-Phe-induced elevation of [Ca2+]i. The response to PAF 
was dependent on external Ca 2+ as it was significantly inhibited by EGTA (85.6+ 5.4~) and Ni 2+ (95.8 +2.1%) but not 
by the dihydropyridine antagonist nimodipine. We conclude that Ca 2+ entry via receptor-operated Ca z+ channels may 
be involved in PAF-induced egranulation f eosinophils. 
Ca 2+ concentration, i tracellular; Platelet-activating factor; Platelet-activating factor antagonist WEB 2086 
1. INTRODUCTION 
Platelet-activating factor (PAF) is now con- 
sidered to be a major inflammatory mediator in 
bronchial asthma [1]. Asthma is characterized by 
infiltration of the airway wall by eosinophils. 
Eosinophil accumulation in lung tissue is 
stimulated by PAF [2]. Eosinophils in turn may be 
involved in the development of bronchial hyper- 
responsiveness and epithelial damage in asthmatic 
airways by releasing their basic proteins such as 
major basic protein, eosinophil cationic protein 
and eosinophil peroxidase [3]. 
Eosinophils are stimulated by a number of 
agents including the calcium ionophore, 
formylmethionyl-leucyl-phenylalanine (fMet-Leu- 
Phe), and phagocytosable particles [3]. In addi- 
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tion, PAF shows potent eosinophil chemotactic ac- 
tivity [4] and stimulates the generation of 
leukotriene C4 in these cells [5]. Furthermore, we 
have demonstrated that PAF releases eosinophil 
peroxidase (EPO) and other granular contents 
from human and guinea pig eosinophils [6]. This 
observation may be of particular pathogenetical 
interest since it links PAF with a putative ffector 
cell in asthma. 
In order to investigate the mechanism of PAF- 
induced eosinophil activation we have studied the 
change in intracellular calcium ion concentration 
([Ca2+]i) of purified guinea pig eosinophils. 
2. MATERIALS AND METHODS 
2.1. Materials 
Hanks balanced salt solution (HBSS) was purchased from 
Flow Laboratories Ltd (Richmansworth, England), Percoll was 
purchased from Pharmacia Fine Chemicals AB (Uppsala, 
Sweden), and octadecyl-PAF and octadecyl-lyso-PAF were ob- 
tained from Bachem (Switzerland). WEB 2086 was kindly 
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donated by Boehringer Ingelheim (lngelheim, FRG). Triton 
X-100 was purchased from BDH Ltd (Poole, England). 
Leukotriene B4 (LTB4), N-formylmethionyl-leucyl-phenylala- 
nine, dimethyl sulfoxide (DMSO), bovine serum albumin 
(BSA), polymyxin B sulfate, EGTA and digitonin were from 
Sigma (Poole, England) and fura-2 acetoxymethyl ester from 
Molecular Probes (Eugene, OR, USA). 
2.2. Preparation of eosinophils 
Eosinophils were obtained from polymyxin B-treated male 
guinea pigs (650-1000 g) by weekly peritoneal lavage [7]. The 
cells were purified using a discontinuous gradient of isomolar 
Percoll solutions (1.100, 1.090, 1.085, 1.080, and 1.070 g/ml) 
as previously described [8]. Eosinophils with a purity of >95070 
and a viability >99070 were found in fractions 3, 4, 5 and 6. The 
fractions were pooled and washed three times in HBSS buffer. 
2.3. Measurements of [Ca2+]i 
The cells were then incubated for 30 rain at 37°C (107 
cells/ml) with 2.5 #M fura-2 as described [9]. After incubation, 
eosinophils were washed three times in calcium-free, Hepes buf- 
fered Tyrode solution and resuspended to a final concentration 
of 1.5 × 106 cells/ml. 2 ml of the cell suspension were dispensed 
into disposable cuvettes and the external Ca 2+ concentration 
([Ca2+]o) adjusted to I mM with CaCI. Cuvettes were transfer- 
red to a Bowman spectrophoto-fluorimeter ( xcitation 330 nm, 
emission 500 nm: 4 nm slit width), fitted with a stirring attach- 
ment for fluorescence r ading at 37°C. Leakage of fura-2 from 
eosinophils was shown to be small as determined by the degree 
of quench in fluorescence signal produced by the addition of 
1 mM Ni 2+. The intracellular calcium concentration ([CaZ+]i) 
was determined by the chelation method and formula [10]. Fma~ 
was measured by lysing with 40/~m digitonin in the presence of 
1 mM Ca 2+. Fmin was determined by adjusting the pH of the 
lysed cells to 8.5 with 20 #12 M NaOH followed by the addition 
of 10 mM EGTA. Cells were allowed to equilibrate at 37°C for 
2 min before the agonist or vehicle was added directly to the 
cell-containing cuvettes. WEB 2086 and the vehicle were added 
1 min before the agonist. 
2.4. Statistics 
Negative log ECso values from each concentration-response 
curve were derived by linear egression analysis of percentage of 
the maximum [Ca2+]i for the agonist versus log concentration 
at concentrations immediately above and below the 5007o 
response l vel. For each stimulus, experiments were performed 
at least three times in duplicate or triplicate by using cell 
preparations from different animals on different days. Results 
were expressed as mean +_ SE and were analysed by Student's 
t-test. 
3. RESULTS 
Addition of PAF to eosinophils loaded with 
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Fig.l. Effect of PAF (A), Iyso-PAF (B) and WEB 2086 (C) on intracellular f ee calcium ion concentration ([Ca2+]i) in eosinophils. 
The trace is a recording of fluorescent output of fura-2-1oaded guinea pig eosinophils (3 × 106 cells/sample). The non-linear vertical 
scale is the result of transforming fluorescent output o eosinophil [Ca2+]i. The traces were obtained from one experiment, but are 
representative of four other experiments. 
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fura-2 produced a rapid elevation of the in- 
tracellular calcium concentration ([CaZ+]i) above 
basal values of 120.7 + 36.5 nM (n = 10) up to ap- 
prox. 1000 nM. The effect of PAF was 
concentration-dependent with a maximal effect 
seen at 1000 nM and a mean ECs0 of 17.6 nM 
(calculated from five independent experiments). 
Increasing PAF concentrations also reduced the 
time to reach both the onset and the maximum of 
response as well as the time interval between them 
(fig.lA). Lyso-PAF was ineffective at concentra- 
tions up to 10/zM (fig.lB). Preincubation with 
specific PAF receptor antagonist WEB 2086 [13] 
for 1 min inhibited the elevation of [Ca2+]i nduced 
by PAF (100 nM) in a dose-dependent manner 
with a corresponding IC5o of 59.5 nM (fig. 1C). 
LTB4 and fMet-Leu-Phe also increased [Caa+]i 
in eosinophils. On a molar basis, PAF and LTB4 
were equipotent whereas for fMet-Leu-Phe higher 
concentrations (I-100/zM) were needed to elicit a 
rise of [Ca2÷]i in eosinophils. In addition, LTB4 
and PAF showed a similar time course, whereas 
FMLP was slower in onset and longer lasting 
(fig.2). After an initial exposure to PAF 
eosinophils were unresponsive to a second applica- 
tion of PAF, indicating homologous desensitiza- 
tion (fig.3A). In contrast, an initial exposure to 
PAF did not affect the responses produced by a 
subsequent application of LTB4 or fMet-Leu-Phe 
(fig.3). 
When eosinophils were stimulated with PAF in 
a CaZ+-free buffer in the presence of 5 mM EGTA, 
[Ca2+]i still displayed a slight rise (fig.4), but it was 
greatly diminished compared with the rise seen at 
1 mM Ca z+. The mean inhibition for 
100 pM-1/zM PAF was 85.6 +_ 5.4 (p < 0.05). 
Replacement of 1 mM [Ca2+]e with 1 mM Ni 2+ 
produced an instantaneous slight quench of the 
signal indicating a small leakage of intracellular 
fura-2. The initial quench is followed by a signifi- 
6161" ,, , t16 t m~. 
196 
112 . . . .  - - ~  
e 
66 tO0 i~4 7nM :OnM 
LTB. LTBII LTBII 
3t6 
196 
112 • • 
66 vehicle I00 rim 300 nM IOO nM 
L'r Btl WEB ZO~I6 LTIIll 
. , o  
112 
66 I UM to ~M 
fMet-Leu-Phe fMet-Leu-Phe 
G16 I D ~ 3t6 
196 
112 ~ -- - 
f~ vehicle 100 ~ 300 nM t00 I~A 
fMet-Leu-Phe WEB ~ fMet.- Le~ -Phe 
Fig.2. Effect of leukotriene B4 and fMet-Leu-Phe on intracellular free calcium concentration i  eosinophils. Panels B and D 
demonstrate he influence of WEB 2086 on both stimuli. Details as described in rigA. 
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Fig.3. Comparison of repeated stimulation ofthe same osinophil sample by PAF (A), leukotriene B4 (C), or fMet-Leu-Phe (D) with 
their effect on independent cell samples (B). Details as described in fig. 1. 
cant prolongation of the response time and a 
marked decrease in the peak elevation of [Ca2+]i 
upon stimulation of PAF. Ni 2+, which are known 
to block calcium-translocating pores [12], pro- 
duced an almost complete inhibition (95.8 _+ 2.1; p 
> 0.05o7o) of elevation in [CaZ+]i elicited by PAF 
at concentrations ranging from 100 pM to 1/~M. 
These data suggest hat the increase in [CaZ+]i in- 
duced by PAF arose mainly from an influx of ex- 
ogenous Ca 2+. Moreover, preincubation of 
eosinophils for 10 min with the dihydropyridine 
antagonist nimodipine up to concentrations of 
10/~M did not affect the elevation of [Ca2+]i by 
PAF, indicating that dihydropyridine-sensitive 
Ca 2+ channels are not involved. 
Finally, exposure of eosinophils to 1 mM Mn ~+ 
led to an instantaneous small sharp drop followed 
by a decline in fluorescence. As for Ni z+, the slight 
drop in fluorescence upon addition of Mn 2+ 
reflects the immediate quenching of leaked ex- 
tracellular fura-2 while the subsequent decline in- 
dicates a moderate influx of Mn 2÷ into the cells 
displacing Ca 2+ from the intracellular fura-2 and 
quenching the fluorescence signal. In contrast o 
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Fig.4. Dose-response curve of PAF-induced [Ca2+]i in the presence of 1 mM Ca 2+ (o), 5 mM EGTA (0), and 1 mM Ni z+ (0). 
[CaZ÷]i s the value obtained by subtracting basal pre-agonist value from the peak post-agonist value. Data are expressed as mean + 
SE of 9 determinations from three independent experiments. 
observations in platelets [21,22], PAF did not 
stimulate Mn 2÷ entry in eosinophils. 
4. DISCUSSION 
The results presented here demonstrate that 
PAF induces a rapid and transient increase of 
[Ca2+]i in guinea pig eosinophils in a dose- 
dependent manner with a maximum effect at 
1000 nM and a mean EC50 of 17.6 riM. Further- 
more, the cellular esponse to PAF was inhibited in 
the presence of WEB 2086 (ECs0 59.5 nM). WEB 
2086 has been shown to be a receptor antagonist of 
PAF with respect to activation and binding to 
platelets [13], neutrophils [14], and U937 cells [9]. 
With eosinophils, its inhibitory action appears to 
be specific to PAF since the agonist at high concen- 
trations (1/2M) did not affect the response seen 
with leukotriene B4 or fMet-Leu-Phe. These results 
suggest hat PAF acts on guinea pig eosinophils 
through a specific, receptor-mediated mechanism. 
There are at least two functionally distinct 
pathways by which PAF increases [Ca2+] f  release 
of calcium from intracellular stores and calcium 
influx through plasma membrane pores. The im- 
portance of extracellular Ca 2+ ([Ca2+]e) in 
response to PAF has been demonstrated in 
platelets [15], macrophages [17], and U937 cells 
[16]. The effect of PAF on eosinophils also ap- 
pears to involve a major influx of [Ca2+]e through 
receptor-mediated pores. PAF-induced rise of 
[Ca2+]i in eosinophils was greatly diminished in the 
presence of submicromolar [CaZ+]o, EGTA, or 
Ni z÷ (fig.4). Moreover, dehydropyridine-sensitive 
Ca 2+ channels do not appear to be involved in the 
ion influx since the dihydropyridine antagonist 
nimodipine has no effect on the PAF-induced 
elevation of [CaZ+]i. 
When eosinophils were sequentially exposed to 
PAF, then leukotriene B4 and then fMet-Leu-Phe, 
the cells produced a full response to each stimulus. 
If the intracellular calcium stores are depleted ur- 
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ing the first st imulat ion, a diminished response to 
subsequent stimuli might occur. However,  this was 
not the case, since repeated appl icat ion of  different 
agonists produced a full response, The results sup- 
port  the concept that receptor-operated influx of  
Ca 2+ is necessary to obtain a maximal  elevation of  
[Ca2+]i, However,  our studies also show a small 
but consistent elevation of  [Ca2+]i elicited by PAF  
both in the absence of  Ca 2+ and in the presence of  
Ni 2+. These results also suggest hat PAF ,  in addi-  
t ion to the st imulated influx, causes release of  
some Ca 2+ from intracel lular stores as previously 
described in platelets, macrophages,  and U937 
[15-17]. Furthermore,  an apparent  increase in 
membrane permeabi l i ty to Mn 2+, as seen in 
platelets in response to PAF  [21,22], was not 
observed in eosinophils.  
PAF  at concentrat ions from 10 nM to 10/tM 
causes eosinophi l  chemotact ic locomot ion [4] and 
eosinophi l  adhesion to endothel ia l  cells [18]. In ad- 
dit ion, PAF  at concentrat ions of  10/zM induces 
leukotr iene C4 synthesis in human eosinophils [5]. 
Furthermore,  we have demonstrated that PAF  is a 
potent degranulat ing agent for human and guinea 
pig eosinophils at concentrat ions ranging f rom 
10/~M to 0.1 nM [6]. The biochemical  mechanism, 
however,  by which PAF  elicits these responses is 
not yet fully understood.  The concentrat ions of  
PAF  needed to elicit the functional effects and to 
increase [Ca2+]i in eosinophils are similar with an 
effect starting at I0 pM and reaching a max imum 
at 10/~M, indicating that the transduct ion signal 
generated by PAF-receptors  in eosinophils may in- 
volve an elevation of [CaZ+]i. A similar relat ion 
between the PAF- induced cellular response and 
[Ca2+]i have been described for per itoneal  
macrophages from mice [17] and guinea pig 
neutrophi ls [19] as well as for platelets [20]. 
In summary,  our results conf i rm that the 
eosinophi l  is a target cell for PAF .  Furthermore,  
we conclude that the response o f  eosinophils to 
PAF  appears to be receptor mediated and that the 
rise of  [CaZ+]i represents an early event in 
eosinophi l  cell activation. Final ly,  the intracel lular 
elevation of  the calcium concentrat ion results 
mainly  f rom an influx of  extracellular Ca 2+ via 
receptor-operated rather than from voltage- 
dependent Ca z+ channels. Since both the 
eosinophi l  and PAF  may play a crucial role in the 
pathogenesis of  asthma our f indings may be of  
part icular  pathophysio logical  relevance. 
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